
I-Next Pharmaceutical Private Limited
About I-Next Pharmaceutical Private Limited
Data last updated:
I-Next Pharmaceutical Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2020PTC137831.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Reetu Srivastava and Sharad Kumar Srivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kh No – 59 Saadil Nagar Kursi Road, Lucknow, Uttar Pradesh, India – 226022.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.18 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹4,144 (net margin 3.5%) and EBITDA of ₹25,679 (EBITDA margin 21.8%).
Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.
Company details
Contact details
I-Next Pharmaceutical Private Limited's registered office is in Lucknow, Uttar Pradesh.
- Registered AddressKh No – 59 Saadil Nagar Kursi Road, Lucknow, Uttar Pradesh, India – 226022
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of I-Next Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of I-Next Pharmaceutical Private Limited, buy the company report.
Financials of I-Next Pharmaceutical Private Limited
FY 2025 filings availableI-Next Pharmaceutical Private Limited reported revenue of ₹1.18 Lakh (up 56% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 56% in the latest year. EBITDA rose 192% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹25,679 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹4,144 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 21.8% | ||
| Net Profit Margin | 3.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of I-Next Pharmaceutical Private Limited, buy the company report.
Board of directors of I-Next Pharmaceutical Private Limited
I-Next Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Reetu Srivastava | Director | 10 Nov 2020 | 5 Years 11 Months | Current |
| Sharad Kumar Srivastava | Director | 10 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
I-Next Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Growcorp Services Private Limited | ₹1.18 Lakh (FY 2021) | -64.0% | Patna, Bihar, India | |||
| Khizan Apparel Private Limited | ₹1.18 Lakh (FY 2024) | Bhilwara, Rajasthan, India | ||||
| Sujag Corporate Services Private Limited | ₹1.18 Lakh (FY 2024) | 163.0% | Kalyan, Maharashtra, India | |||
| Landmark Commodities Trade Private Limited | ₹1.18 Lakh (FY 2018) | -64.0% | Kolkata, West Bengal, India | |||
| Regal Overseas Private Limited | ₹1.18 Lakh (FY 2025) | -55.0% | Sirhind, Punjab, India | |||
| I-Next Pharmaceutical Private Limitedthis company | ₹1.18 Lakh (FY 2023) | ₹4,144 | 3.5% | 56.0% | Lucknow, Uttar Pradesh, India | |
| Sarla Harish Exports Private Limited | ₹1.18 Lakh (FY 2018) | -7.0% | New Delhi, Delhi, India | |||
| Thinkfix Enterprises Private Limited | ₹1.18 Lakh (FY 2024) | 15.0% | Salem, Tamil Nadu, India | |||
| Padma Creation Designer Private Limited | ₹1.18 Lakh (FY 2021) | -87.0% | Barrachpore, West Bengal, India | |||
| Sashi Fiscal Services Pvt. Ltd. | ₹1.18 Lakh (FY 2025) | -76.0% | Kolkata, West Bengal, India | |||
| Everagro Crop Science Private Limited | ₹1.18 Lakh (FY 2022) | Barhaj, Uttar Pradesh, India |
To see the full peer comparison of I-Next Pharmaceutical Private Limited, buy the company report.
Legal cases
I-Next Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Torrent Pharmaceuticals Ltd. | Pending |
To see the full case history of I-Next Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for I-Next Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for I-Next Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
I-Next Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Reetu Srivastava was appointed as Director on 10 Nov 2020.
Frequently asked questions
I-Next Pharmaceutical is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 November 2020 (6+ years old) and is registered under CIN U24299UP2020PTC137831.
I-Next Pharmaceutical has 2 current directors:
- Reetu Srivastava - Director
- Sharad Kumar Srivastava - Director
The latest financial statements of I-Next Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of I-Next Pharmaceutical is U24299UP2020PTC137831. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
I-Next Pharmaceutical has 1 court case on record: 1 filed against it. 1 is pending.
I-Next Pharmaceutical was incorporated on 10 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of I-Next Pharmaceutical by revenue are Growcorp Services Private Limited, Khizan Apparel Private Limited, Sujag Corporate Services Private Limited, Landmark Commodities Trade Private Limited, Regal Overseas Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Reetu Srivastava was appointed as Director on 10 Nov 2020. Sharad Kumar Srivastava was appointed as Director on 10 Nov 2020.
The registered office of I-Next Pharmaceutical is at Kh No – 59 Saadil Nagar Kursi Road, Lucknow, Uttar Pradesh, India – 226022.
I-Next Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
I-Next Pharmaceutical can be reached at its registered office: Kh No – 59 Saadil Nagar Kursi Road, Lucknow, Uttar Pradesh, India – 226022.

